Basic Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Mar 14, 2019; 25(10): 1210-1223
Published online Mar 14, 2019. doi: 10.3748/wjg.v25.i10.1210
Table 1 Association of nuclear factor erythroid 2-like 3 expression with clinicopathological features of hepatocellular carcinoma patients in The Cancer Genome Atlas dataset n (%)
VariableNFE2L3 expression
Total casesP-value
Low (n = 172)High (n = 172)
Tumor grade0.0006
G1/2122 (70.9)91 (52.9)213
G3/450 (29.1)81 (47.1)131
T stage0.0070
T1100 (58.1)71 (41.2)171
T235 (20.3)52 (30.2)87
T3/437 (21.5)49 (28.5)86
Pathologic stage0.0138
I98 (57.0)71 (41.2)169
II35 (20.3)50 (29.1)85
III/IV39 (22.7)51 (29.7)90